US is the hub of clinical trials conducted in the medical world. This statement stands true no longer true. Most of the clinical today are conducted in the foreign nation like Russia, China, Brazil, Poland, Uganda, and Romania. Economic feasibility is the main reason behind conducting the clinical trials in faraway locations in spite of the sponsor, the pharmaceutical company having its base in US. The clinical trial industry turned into big business worth $30 billion in these faraway nations.
When these clinical trials are conducted in foreign nations, few common security questions that are whether these clinical trials are properly monitored by FDA regulations? Do the volunteers have the clear picture about the informed consent? Are they actually aware that they are participation in the clinical trials? If clinical trial is able to give the right answer to all these queries, then globalization of the clinical trials turn to be very economical.
No comments:
Post a Comment